Govt bans 14 fixed dose combination drugs including Nimesulide and Paracetamol, citing health risk
FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio
The Centre has banned 14 fixed dose combination (FDC) drugs in the country saying that there is "no therapeutic justification" for these medicines and they may involve "risk" to people.
FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio.
The move came following recommendations by an expert committee. The Health Ministry has also issued a notification on this regard.
These 14 fixed dose combination drugs including Nimesulide and Paracetamol dispersible tablets and Chlopheniramine Maleate and Codeine syrup.
FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio.
These banned drugs included those used for treating common infections, cough and fever combinations such as: Nimesulide Paracetamol dispersible tablets, Chlopheniramine Maleate Codeine Syrup, Pholcodine Promethazine, Amoxicillin Bromhexine and Bromhexine Dextromethorphan Ammonium Chloride Menthol, Paracetamol Bromhexine Phenylephrine Chlorpheniramine Guaiphenesin and Salbutamol Bromhexine.
Earlier in 2016, the government had announced the ban on the manufacture, sale and distribution of 344 drug combinations after an expert panel, set up at the behest of the Supreme Court had stated they were being sold to patients without scientific data and the order was challenged by the manufacturers in court.
The current banned 14 FDCs are also part of those 344 drug combinations.
